Abstract: VKEY-BIO (Shanghai) Biotechnology Co., Ltd. has been awarded a national-level qualification certification, officially entering the ranks of national high-tech enterprises (Certificate Issued: December 14, 2022, Certificate Number: GR202231005500).
On January 4, 2023, the Office of the National Leading Group for the Management of High-Tech Enterprise Recognition issued the "Announcement on the Filing of the Third Batch of High-Tech Enterprises Recognized by the Shanghai Recognition Authority in 2022," in which VKEY-BIO (Shanghai) Biotechnology Co., Ltd. was included. The announcement information is as follows:
The recognition of high-tech enterprises is jointly formulated by the Ministry of Science and Technology, the Ministry of Finance, and the State Taxation Administration, primarily evaluating innovation capabilities from four dimensions: intellectual property rights, the transformation capacity of scientific and technological achievements, the level of research and development organization management, and the growth of the enterprise. High-tech enterprises are innovative enterprises with high growth potential that are strongly supported by the state and are an important national-level qualification certification. The recognition of VKEY-BIO (Shanghai) Biotechnology Co., Ltd. as a high-tech enterprise is an acknowledgment of VKEY-BIO scientific research capabilities and operational management level, demonstrating VKEY-BIO technological innovation strength and market development capabilities.
About VKEY-BIO
VKEY-BIO, founded in 2019, is a biotechnology company dedicated to the research and production of reagents for life sciences. Recognized as a "High-Tech Enterprise," an "Innovative SME," and a "Technology-Based SME" in China, our focus is on providing high-quality reagents. Our mission is to contribute to the reduction of drug discovery costs by offering comprehensive and customized solutions for your research.
Our products primarily based on Luminescent and TR-FRET technology platforms, designed for drugs screening and validation purposes. Notably, our independently developed KeyTec® TR-FRET technology employs the stable energy donor (Solar Eu/Tb) and the stable energy acceptor (LA/HX) in a time-resolved fluorescence resonance energy transfer system. TR-FRET is known for its ease of use, homogeneity (no wash), low background, wide range and robustness. Furthermore, our independently developed KeyTec® Luminescent is known for its high sensitivity and robust luminescence. We eagerly anticipate the opportunity to collaborate with you, fostering advancements in life science research together.
English
